- IN₹6.24bn
- IN₹8.38bn
- IN₹6.50bn
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility
India's Wanbury drops after US drug regulator flags six observations at Andhra facility
Brief: Wanbury Says USFDA Inspection At Tanuku Facility Conducted From July 13 To 17
Brief: Wanbury Approves Incorporation Of Subsidiary Company In India
Brief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil
Brief: Wanbury Ltd Launches Commercial Production Of Anaesthetic API
India's Wanbury jumps after facility clears Brazil regulator's inspection
Indian pharma firm Wanbury gains on product launch plans
Brief: Wanbury To Issue NCDs Up To 2 Billion Rupees
Brief: Wanbury Ltd Completes ANVISA Audit At Tanuku Plant
Brief: Wanbury Says Tanuku Plant Completes Anvisa Inspection
Brief: Wanbury- Got Certificate Of Suitability For Launch Of Dextromethorpha From European Regulator